MedTrace Logo

Graded Exposure in Patients With Painful Diabetic Neuropathy

NCT03066570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-12-03

No results posted yet for this study

Summary

Objective: To investigate the effects of a cognitive behavioural intervention targeting specific fears in patients with painful diabetic neuropathy, on physical activity and quality of life.

Conditions

  • Painful Diabetic Neuropathy
  • Diabetic Neuropathies, Painful
  • Neuralgia, Diabetic

Interventions

BEHAVIORAL

Graded Exposure

Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity.

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-03-18
Completion
2019-03-18

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03066570 on ClinicalTrials.gov